Building Competency in Diabetes Education THE ESSENTIALS

TREATMENT MODALITIES: PHARMACOLOGICAL THERAPIES | 6-130

92. Tucker ME. Sept 13, 2016. Medscape. https://www.medscape.com/viewarticle/868717_print. Accessed September 6, 2018. 93. Garg SK, Henry RR, Banks P, et al. Effects of sotagliflozin added to insulin in patients with type 1 diabetes. N Engl J Med 2017;377:2337-48. 94. AA PHARMA INC. Gliclazide MR and Gliclazide product monograph. Vaughn: AA Pharma, 2010. 95. Sanofi-Aventis Canada Inc. NEW Amaryl product monograph. Laval: Sanofi-Aventis Canada, 2016. 96. Paneni F, Luscher TF. Cardiovascular protection in the treatment of type 2 diabetes: A review of clinical trial results across drug classes. Am J Med 2017;130(Suppl 6):S18-S29. 97. Bajaj M, DeFronzo RA. Combination therapy in type 2 diabetes. In DeFronzo RA, Ferrannini E, Keen H, et al, eds. International Textbook of Diabetes Mellitus. 3rd ed. Vol.1. Toronto: Wiley, 2004:915-49. 98. Sanofi. Pr Diabeta product monograph version 6.0. Laval: Sanofi, 2016. 99. DeFronzo RA, Ferrannini E, Keen H, et al. Combination therapy in type 2 diabetes. In DeFronzo RA, Ferrannini E, Keen H, et al, eds. International Textbook of Diabetes Mellitus. 3rd ed. Vol. 1. Toronto: Wiley, 2004:915-50. 100. American Diabetes Association. Standards of medical care in diabetes 2018 older adults. Diabetes Care 2018;41(Suppl 1):S119-S125. 101. Charpentier G, Riveline JP, Varroud-Vial M. Management of drugs affecting blood glucose in diabetic patients with renal failure. Diabetes Metab 2000;26(Suppl 4):73-85. 102. Novo Nordisk Canada Inc. NEW repaglinide product monograph. Mississauga: Novo Nordisk Canada, 2015. 103. McCulloch DK. Alpha-glucosidase inhibitors and lipase inhibitors for treatment of diabetes mellitus. In Rose BD, ed. UpToDate. Wellesley: UpToDate, 2008. 104. Bayer Inc. Glucobay product monograph. Mississauga: Bayer, 2014. 105. Miser WF. The management of type 2 diabetes mellitus focus on quality. Primary Care 2007;34:1-38. 106. Drugdex System. http://www.micromedex.com/products/drugdex. Accessed January 22, 2019. 107. Deeks ED, Keam SJ. Rosiglitazone: A review of its use in type 2 diabetes. Drugs 2007;67:2747-79.